Plunkett Research Online: Medical Prognosis

MEDICAL PROGNOSIS (MDIPF:GREY) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Allarity Therapeutics AS is a late clinical-stage, precision medicine company actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers guided by its proprietary drug response predictor technology, the DRP platform. The product portfolio includes.....



Medical Prognosis
Ticker: MDIPF
Exchange: GREY
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 45 21701049
Fax:
Address: Venlighedsvej 1
Horsholm, DK-2970 Denmark

Map
Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
Contacts Description

Allarity Therapeutics AS is a late clinical-stage, precision medicine company actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers guided by its proprietary drug response predictor technology, the DRP platform. The product portfolio includes.....See More See More

Auditor: PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: